Rimegepant Sulfate vs Tofacitinib

## Rimegepant Sulfate vs Tofacitinib: Overview

This comparison examines the pharmacological differences between **Rimegepant Sulfate** and **Tofacitinib**.

## Mechanism of Action

**Tofacitinib**: Pan-JAK inhibitor with preference for JAK1 and JAK3 blocking pro-inflammatory cytokine signaling.

## Pharmacokinetics

**Half-life**: Rimegepant Sulfate — N/A; Tofacitinib — 3.2 hours.

## Chemical Properties

**Molecular Formula**: Rimegepant Sulfate — N/A; Tofacitinib — C16H20N6O.

**Molecular Weight**: Rimegepant Sulfate — N/A; Tofacitinib — 312.3700 g/mol.

**Type**: Rimegepant Sulfate — Small molecule; Tofacitinib — Small molecule.